These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Overview of obesity in Mainland China. Chen CM Obes Rev; 2008 Mar; 9 Suppl 1():14-21. PubMed ID: 18307694 [TBL] [Abstract][Full Text] [Related]
29. Agro-food industry growth and obesity in China: what role for regulating food advertising and promotion and nutrition labelling? Hawkes C Obes Rev; 2008 Mar; 9 Suppl 1():151-61. PubMed ID: 18307719 [TBL] [Abstract][Full Text] [Related]
30. Overview of the HIV/AIDS epidemic, scientific research and government responses in China. Wang L AIDS; 2007 Dec; 21 Suppl 8():S3-7. PubMed ID: 18172388 [TBL] [Abstract][Full Text] [Related]
31. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal. Flan B; Arrabal S Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602 [TBL] [Abstract][Full Text] [Related]
32. Globalisation and blood safety. Farrugia A Blood Rev; 2009 May; 23(3):123-8. PubMed ID: 19081166 [TBL] [Abstract][Full Text] [Related]
33. No evidence of over-reporting of SARS in mainland China. Liu W; Han XN; Tang F; Borsboom GJ; Yang H; Cao WC; de Vlas SJ Trop Med Int Health; 2009 Nov; 14 Suppl 1():46-51. PubMed ID: 19814761 [TBL] [Abstract][Full Text] [Related]
34. Proteomics for quality-control processes in transfusion medicine. D'Alessandro A; Zolla L Anal Bioanal Chem; 2010 Sep; 398(1):111-24. PubMed ID: 20496175 [TBL] [Abstract][Full Text] [Related]
35. [Blood and plasma product safety from the viewpoint of public health officials]. Willkommen H Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):497-500. PubMed ID: 10494371 [No Abstract] [Full Text] [Related]
36. The European Blood Directive: a new era of blood regulation has begun. Faber JC Transfus Med; 2004 Aug; 14(4):257-73. PubMed ID: 15285722 [No Abstract] [Full Text] [Related]
37. The plasma supply in Japan. Omokawa S; Abe M Transfus Apher Sci; 2020 Apr; 59(2):102749. PubMed ID: 32179007 [No Abstract] [Full Text] [Related]
38. Blood safety--a focus on plasma derivatives in Mainland China. Zhu YM Dev Biol (Basel); 2007; 127():175-81. PubMed ID: 17486891 [TBL] [Abstract][Full Text] [Related]